14:00 - 17:10
主持人 Moderator
- 江厚佳, 弘盛资本创始管理合伙人
- JIANG Houjia, Founding Managing Partner , Hongsheng Capital
14:05 - 16:20
- 第一阶段：主题报告
- Session I: Keynote Speech
14:05 - 14:35
- 主题报告
- Keynote Speech
- 合成免疫技术驱动的NK细胞治疗
- Synthetic Immunology-drived NK Cell Therapy
- 王珣, 华盖资本首席投资官
- Cynix WANG, CIO of Huagai Capital, Huagai Healthcare Investment Management (Beijing) Co., Ltd.
14:35 - 15:00
- 主题报告
- Keynote Speech
- 多重基因编辑技术创制及通用免疫细胞治疗应用
- Development of Multiplex Gene Editing Tools for Universal Immune Cell Therapy
- 王冠琳, 苏利文·克伦威尔律师事务所律师
- WANG Guanlin, Associate, Sullivan & Cromwell LLP
15:00 - 15:25
- 主题报告
- Keynote Speech
- CAR-T细胞发展的关键挑战和对策
- Key Challenges and Strategies for CAR-T Development
- 杨秀慧, 苏利文·克伦威尔律师事务所律师
- Stella YANG, Associate, Sullivan & Cromwell LLP
15:25 - 15:50
- 主题报告
- Keynote Speech
- 技术创新驱动CGT领域价值创造
- Driving Value Creation in CGT through Technological Innovation
- 万昭奎, 凌科药业（浙江）股份有限公司创始人、董事长、CEO
- WAN Zhaokui, Founder, Chairman of the Board, Executive Director and CEO, Lynk Pharmaceuticals Co., Ltd.
15:50 - 17:00
- 第二阶段：主题讨论
- Session II: Panel
15:50 - 17:00
- 主题讨论
- Panel
- CGT创新生态建设与全球竞争力构建
- From Innovation Hub to Global Leadership: Building CGT Competitiveness
主持人 Moderator
- 陈启宇, 复星国际执行董事兼联席首席执行官
- CHEN Qiyu, Executive Director and Co-CEO, Fosun International
讨论嘉宾：
Panelist:
- 单国洪, 中国医药创新促进会副会长，百济神州高级副总裁，大中华区、中亚及南亚区总经理
- Sean SHAN, Vice President of PhIRDA,
Senior Vice President and General Manager of Greater China, Central & South Asia, BeOne Medicines
- 汪洋, 洪泰基金医药医疗基金主管合伙人
- ,
- 李稳狮, 中国民生银行副行长
- LI Wenshi, Executive Vice President of China Minsheng Bank
- 梁锦, 中金公司董事总经理、投行委委员
- LIANG Jin, Member of the Management Committee of the Investment Banking Department, CICC
会议咨询